Picked this up when it was oversold with 29% return at the moment, with a hold of the 50 day $2.77 and resistance break at $2.91 could see $3.50.... blue sky would be the gaps up in the +$6 range... hourly is way overbought at the moment so may exit and look for another entry. Hourly volume is also relatively high.
Financials due on 2/8: A clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer therapeutics, today announced that the Company will report fourth quarter and full year 2017 financial results and operational highlights on Thursday, March 8th, 2018
Financials due on 2/8: A clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer therapeutics, today announced that the Company will report fourth quarter and full year 2017 financial results and operational highlights on Thursday, March 8th, 2018
Trade active:
50 DMA @ $2.74 is providing support (50 WMA @ $4) and is currently above resistance in $2.91 / $2.95 range. Earnings call today so we will see if they lost less money then they anticipated. Holding over 40% profit on this one so sold half and will keep an eye on the the 50 day to see if support continues.
Trade closed: target reached:
Bounce off of $3.50 again today.. sold at $3.48 from $2.15